InMed Pharmaceuticals (INM) Shares Outstanding (Entity) (2019 - 2026)
InMed Pharmaceuticals (INM) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 834.66 Mn |
| 10 | InMed Pharmaceuticals | 6.44 Mn | 1.20 Mn | - | 3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.31 Mn |
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Jun 30, 2025 | 975,985.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 724,152.00 |
| Sep 30, 2024 | 666,969.00 |
| Jun 30, 2024 | 445,908.00 |
| Mar 31, 2024 | 480,649.00 |
| Dec 31, 2023 | 398,673.00 |
| Sep 30, 2023 | 166,410.00 |
| Jun 30, 2023 | 122,423.00 |
| Mar 31, 2023 | 166,410.00 |
| Dec 31, 2022 | 115,026.00 |
| Sep 30, 2022 | 45,438.00 |
| Jun 30, 2022 | 32,533.00 |
| Mar 31, 2022 | 28,568.00 |
| Dec 31, 2021 | 28,274.00 |
| Sep 30, 2021 | 20,654.00 |
| Jun 30, 2021 | 16,101.00 |